No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr17:63220600-63224400 |
Weak transcription |
Esophagus |
oesophagus
|
2 |
chr17:63220600-63224400 |
Weak transcription |
Right Atrium |
heart
|
3 |
chr17:63221400-63224200 |
Weak transcription |
Ovary |
ovary
|
4 |
chr17:63221600-63228000 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
5 |
chr17:63222400-63224800 |
Weak transcription |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
6 |
chr17:63222600-63224800 |
Weak transcription |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
7 |
chr17:63222800-63224400 |
Weak transcription |
Fetal Lung |
lung
|
8 |
chr17:63223400-63224600 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
9 |
chr17:63223400-63225400 |
Enhancers |
Spleen |
Spleen
|
10 |
chr17:63223600-63224400 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
11 |
chr17:63223600-63224400 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
12 |
chr17:63223600-63225400 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
13 |
chr17:63223800-63224400 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
14 |
chr17:63223800-63225200 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
15 |
chr17:63223800-63226200 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
16 |
chr17:63224000-63224200 |
Enhancers |
Lung |
lung
|
17 |
chr17:63224000-63224400 |
Bivalent Enhancer |
Primary hematopoietic stem cells short term culture |
blood
|
18 |
chr17:63224000-63225200 |
Enhancers |
Foreskin Melanocyte Primary Cells skin01 |
Skin
|
19 |
chr17:63224000-63226400 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|